# Clinical Trial Landscape: 10_gastric_her2_msi_high

*Generated: 2026-01-05 18:32:32*

## Summary

- **Total Trials**: 100
- **Flagged for Review**: 0
- **Search Terms Used**: 11

## Phase Distribution

| Phase | Count | Distribution |
|-------|-------|--------------|
| Phase 2 | 26 | █████ 26.0% |
| Phase 1 | 23 | ████ 23.0% |
| Phase 1/Phase 2 | 20 | ████ 20.0% |
| Unknown | 11 | ██ 11.0% |
| Phase 3 | 10 | ██ 10.0% |
| Not Applicable | 5 | █ 5.0% |
| Early Phase 1 | 5 | █ 5.0% |

## Status Distribution

- **Recruiting**: 92 (92.0%)
- **Not yet recruiting**: 6 (6.0%)
- **Enrolling by invitation**: 2 (2.0%)

## Top Sponsors

| Sponsor | Trial Count |
|---------|-------------|
| Stanford University | 3 |
| National Cancer Institute (NCI) | 3 |
| M.D. Anderson Cancer Center | 3 |
| Novartis Pharmaceuticals | 3 |
| Sidney Kimmel Comprehensive Cancer Center at Johns | 2 |
| Baylor College of Medicine | 2 |
| University of California, San Francisco | 2 |
| University of California, Irvine | 2 |
| AstraZeneca | 2 |
| Washington University School of Medicine | 2 |
| Mayo Clinic | 2 |
| GlaxoSmithKline | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Merck Sharp & Dohme LLC | 2 |
| University of Nebraska | 1 |

## Interventions

| Intervention | Occurrences |
|--------------|-------------|
| Pembrolizumab | 8 |
| Nivolumab | 8 |
| Paclitaxel | 6 |
| Oral MRT-2359 | 6 |
| Abemaciclib | 5 |
| Biospecimen Collection | 5 |
| Placebo | 5 |
| Cisplatin | 4 |
| Computed Tomography | 4 |
| Magnetic Resonance Imaging | 4 |
| Fulvestrant | 4 |
| Bevacizumab | 4 |
| Regorafenib | 3 |
| Relatlimab | 3 |
| Positron Emission Tomography | 3 |
| pembrolizumab | 3 |
| Radiation Therapy | 3 |
| Tucatinib | 3 |
| Palbociclib | 2 |
| Anastrozole | 2 |

## Geographic Distribution

| Country | Trial Count |
|---------|-------------|
| United States | 100 |
| Spain | 21 |
| France | 17 |
| Canada | 17 |
| South Korea | 16 |
| United Kingdom | 15 |
| Australia | 14 |
| Germany | 14 |
| Italy | 14 |
| Belgium | 13 |
| Japan | 12 |
| China | 11 |
| Taiwan | 9 |
| Israel | 7 |
| Poland | 7 |

## Search Term Provenance

| Term | Source | Confidence |
|------|--------|------------|
| HER2 positive | manual | 1.0 |
| HER2positive | manual | 0.9 |
| HER2-positive | manual | 0.9 |
| MSI-High | manual | 1.0 |
| gastric cancer | manual | 1.0 |
| HER2 positive gastric cancer | manual | 1.0 |
| MSI-High gastric cancer | manual | 1.0 |
| HER2 positive metastatic gastric cancer | llm | 0.9 |
| stomach cancer | llm | 0.8 |
| gastric adenocarcinoma | llm | 0.8 |
| HER2+ | llm | 0.9 |

## All Trials

| NCT ID | Phase | Status | Sponsor | Title |
|--------|-------|--------|---------|-------|
| [NCT05038098](https://clinicaltrials.gov/study/NCT05038098) | Phase 1 | Not yet recruiting | M.D. Anderson Cancer... | Magnetic Sentinel Lymph Node Mappin... |
| [NCT04383262](https://clinicaltrials.gov/study/NCT04383262) | Phase 2 | Not yet recruiting | Medical College of W... | A 12-Week Randomized, Double-Blind,... |
| [NCT06502171](https://clinicaltrials.gov/study/NCT06502171) | Phase 1 | Not yet recruiting | Girish Dhall, MD | A Phase 1/1b/2 Study of Cabozantini... |
| [NCT06224673](https://clinicaltrials.gov/study/NCT06224673) | Phase 2 | Not yet recruiting | Laura Huppert, MD, B... | Phase II Open-label Study of ARX788... |
| [NCT06590454](https://clinicaltrials.gov/study/NCT06590454) | Phase 2 | Recruiting | Katherine Garman | Therapeutic Intervention to Reverse... |
| [NCT06824363](https://clinicaltrials.gov/study/NCT06824363) | Early Phase 1 | Not yet recruiting | University of Califo... | Proof of Principle Study Evaluating... |
| [NCT06828588](https://clinicaltrials.gov/study/NCT06828588) | Early Phase 1 | Not yet recruiting | Vanderbilt-Ingram Ca... | Pilot Study of [68Ga]Ga-ABY-025 Ima... |
| [NCT06525766](https://clinicaltrials.gov/study/NCT06525766) | Phase 2 | Recruiting | Mayo Clinic | Single Arm Pilot Trial of Adaptive ... |
| [NCT04107077](https://clinicaltrials.gov/study/NCT04107077) | Phase 2 | Recruiting | University of Chicag... | A Phase IIa Study of Laparoscopic H... |
| [NCT06844669](https://clinicaltrials.gov/study/NCT06844669) | Phase 2 | Recruiting | Washington Universit... | HER2HEART-US: Primary Prevention of... |
| [NCT06840483](https://clinicaltrials.gov/study/NCT06840483) | Phase 2 | Recruiting | BicycleTx Limited | Phase 2 Study of Zelenectide Pevedo... |
| [NCT06686394](https://clinicaltrials.gov/study/NCT06686394) | Phase 1/Phase 2 | Recruiting | Merck Sharp & Dohme ... | HERTHENA-Breast-01: A Phase 1b/2, M... |
| [NCT06552260](https://clinicaltrials.gov/study/NCT06552260) | Early Phase 1 | Recruiting | Ugonma Chukwueke | A Surgical Window of Opportunity Cl... |
| [NCT06730750](https://clinicaltrials.gov/study/NCT06730750) | Phase 1/Phase 2 | Recruiting | Bristol-Myers Squibb | A Phase 1/2a, Multicenter, Open-lab... |
| [NCT06695845](https://clinicaltrials.gov/study/NCT06695845) | Phase 2 | Recruiting | Jazz Pharmaceuticals | A Phase 2, Open-label, Multicenter ... |
| [NCT06628310](https://clinicaltrials.gov/study/NCT06628310) | Phase 2 | Recruiting | AbbVie | A Phase 2 Randomized Study to Evalu... |
| [NCT06710847](https://clinicaltrials.gov/study/NCT06710847) | Phase 1/Phase 2 | Recruiting | GlaxoSmithKline | A Phase 1/2 First-Time-in-Human, Op... |
| [NCT05736367](https://clinicaltrials.gov/study/NCT05736367) | Not Applicable | Recruiting | Rutgers, The State U... | Pilot Study to Investigate the Meta... |
| [NCT06678269](https://clinicaltrials.gov/study/NCT06678269) | Phase 1 | Recruiting | Memorial Sloan Kette... | A Phase I Study of Concurrent Abema... |
| [NCT06562192](https://clinicaltrials.gov/study/NCT06562192) | Phase 1 | Recruiting | Novartis Pharmaceuti... | Phase I Open-label, Multi-center St... |
| [NCT06625515](https://clinicaltrials.gov/study/NCT06625515) | Phase 1 | Recruiting | Accent Therapeutics | A Phase 1/2, Open-Label, Dose-Escal... |
| [NCT06623201](https://clinicaltrials.gov/study/NCT06623201) | Phase 1 | Recruiting | Nathalie Zeitouni | Blue-Light Photodynamic Therapy and... |
| [NCT06362369](https://clinicaltrials.gov/study/NCT06362369) | Phase 1/Phase 2 | Recruiting | 7 Hills Pharma, LLC | A Phase 1b/2a Multi-Center, Dose Es... |
| [NCT06590857](https://clinicaltrials.gov/study/NCT06590857) | Phase 1/Phase 2 | Recruiting | RayzeBio, Inc. | Phase 1b/2 Open-label Trial of 225A... |
| [NCT06006923](https://clinicaltrials.gov/study/NCT06006923) | Phase 2 | Recruiting | Anwaar Saeed | Randomized Trial of Regorafenib in ... |
| [NCT06356311](https://clinicaltrials.gov/study/NCT06356311) | Phase 3 | Recruiting | Merck Sharp & Dohme ... | A Phase 3, Multicenter, Open-label,... |
| [NCT06242470](https://clinicaltrials.gov/study/NCT06242470) | Phase 1 | Recruiting | MacroGenics | A Phase 1/1b First-in-Human, Open L... |
| [NCT06138808](https://clinicaltrials.gov/study/NCT06138808) | N/A | Enrolling by invitation | Duke University | Prognostic Value of the 5-SENSE Sco... |
| [NCT06176261](https://clinicaltrials.gov/study/NCT06176261) | Phase 2 | Recruiting | Sarah Sammons, MD | DATO-BASE: A Phase 2 Trial of DATOp... |
| [NCT06241456](https://clinicaltrials.gov/study/NCT06241456) | Phase 1 | Recruiting | Fate Therapeutics | A Phase 1 Study of FT825/ONO-8250, ... |
| [NCT05986604](https://clinicaltrials.gov/study/NCT05986604) | Not Applicable | Recruiting | University of Califo... | NIA_Improving Sleep and Circadian F... |
| [NCT05950945](https://clinicaltrials.gov/study/NCT05950945) | Phase 3 | Recruiting | Daiichi Sankyo | A Phase 3b, Multicenter, Global, In... |
| [NCT06058377](https://clinicaltrials.gov/study/NCT06058377) | Phase 3 | Recruiting | National Cancer Inst... | Phase III Trial Of Neoadjuvant Durv... |
| [NCT06131840](https://clinicaltrials.gov/study/NCT06131840) | Phase 1 | Recruiting | Seagen, a wholly own... | An Open-label Phase 1 Study to Inve... |
| [NCT06016738](https://clinicaltrials.gov/study/NCT06016738) | Phase 3 | Recruiting | Olema Pharmaceutical... | A Phase 3 Randomized, Open-Label St... |
| [NCT05997056](https://clinicaltrials.gov/study/NCT05997056) | Phase 2 | Recruiting | Aadi Bioscience, Inc... | A Phase 2 Multi-center, Open-label,... |
| [NCT06047379](https://clinicaltrials.gov/study/NCT06047379) | Phase 1/Phase 2 | Recruiting | Neonc Technologies, ... | An Open-label Phase 1/2 Dose Findin... |
| [NCT05696626](https://clinicaltrials.gov/study/NCT05696626) | Phase 3 | Recruiting | Sermonix Pharmaceuti... | An Open Label, Randomized, Multicen... |
| [NCT05894239](https://clinicaltrials.gov/study/NCT05894239) | Phase 3 | Recruiting | Hoffmann-La Roche | A Phase III, Multicenter, Randomize... |
| [NCT05986279](https://clinicaltrials.gov/study/NCT05986279) | Not Applicable | Recruiting | University of Montan... | Improving Psychological and Vestibu... |
| [NCT06270706](https://clinicaltrials.gov/study/NCT06270706) | Phase 1 | Recruiting | Pliant Therapeutics,... | A Phase 1a/1b Multicenter, Open-lab... |
| [NCT06037837](https://clinicaltrials.gov/study/NCT06037837) | N/A | Enrolling by invitation | Memorial Sloan Kette... | Generalized Robotic Skills Assessme... |
| [NCT05855200](https://clinicaltrials.gov/study/NCT05855200) | Phase 3 | Recruiting | GlaxoSmithKline | A Phase 3, Open-Label, Randomized S... |
| [NCT05748834](https://clinicaltrials.gov/study/NCT05748834) | Phase 2 | Recruiting | SCRI Development Inn... | Phase 2 Single Arm Trial With a Saf... |
| [NCT05313243](https://clinicaltrials.gov/study/NCT05313243) | Phase 2 | Recruiting | Yale University | Phase 2 Study of Pembrolizumab and ... |
| [NCT05985655](https://clinicaltrials.gov/study/NCT05985655) | Phase 1/Phase 2 | Recruiting | Exscientia AI Ltd., ... | A Phase 1/2 Open-label Multicenter ... |
| [NCT05838768](https://clinicaltrials.gov/study/NCT05838768) | Phase 1 | Recruiting | Novartis Pharmaceuti... | An Open-label, Multi-center Phase I... |
| [NCT05520099](https://clinicaltrials.gov/study/NCT05520099) | N/A | Recruiting | Elephas | Observational Basket Trial to Colle... |
| [NCT05826964](https://clinicaltrials.gov/study/NCT05826964) | Phase 2 | Recruiting | University of Miami | Levels of Circulating Tumor DNA as ... |
| [NCT05187182](https://clinicaltrials.gov/study/NCT05187182) | Phase 1 | Recruiting | Washington Universit... | Phase I Trial of CA-4948 in Combina... |

*... and 50 more trials (see trials.csv for full list)*
